Pfizer Inc. buy Scotiabank
Start price
14.11.25
/
50%
€21.90
Target price
14.11.26
-
Performance (%)
0.57%
Price
12.12.25
€22.03
Summary
This prediction is currently active. The BUY prediction by Scotiabank for Pfizer Inc. is nearly unchanged. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pfizer Inc. | -1.454% |
| iShares Core DAX® | 0.734% |
| iShares Nasdaq 100 | -2.686% |
| iShares Nikkei 225® | -2.261% |
| iShares S&P 500 | -1.346% |
Comments by Scotiabank for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for PFE provided by MarketBeat